Ion beam radiobiology and cancer: Time to update ourselves

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1796, Issue 2, 2009, Pages 216-229

  Fokas, Emmanouil ^a   Kraft, Gerhard ^b   An, Hanxiang ^a   Engenhart Cabillic, Rita ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b GSI Helmholtzzentrum für Schwerionenforschung ^*  (Germany)

Author keywords

Cancer; High LET; Particle beam; Radiobiology; RBE

Indexed keywords

REACTIVE OXYGEN METABOLITE;

BIOPHYSICS; BYSTANDER EFFECT; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CLINICAL TRIAL; DNA DAMAGE; GENOMIC INSTABILITY; HEAD AND NECK TUMOR; HUMAN; HYPOXEMIA; ION THERAPY; LINEAR ENERGY TRANSFER; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MALIGNANT TRANSFORMATION; MICROENVIRONMENT; NONHUMAN; OSTEOSARCOMA; PARTICLE RADIATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION BEAM; RADIATION CARCINOGENESIS; RADIATION MUTAGENESIS; RADIATION SICKNESS; RADIOBIOLOGY; RECTUM CANCER; REOXYGENATION; REVIEW; SKULL TUMOR; SOFT TISSUE SARCOMA;

ANIMALS; BYSTANDER EFFECT; CARBON; CELL CYCLE; DNA DAMAGE; GENOMIC INSTABILITY; HEAVY IONS; HUMANS; LINEAR ENERGY TRANSFER; NEOPLASMS; PROTONS; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 70349275176     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2009.07.005     Document Type: Review

References (239)

1. Stone R.S. Neutron therapy and specific ionization. Am. J. Roentgenol. Radium Ther. Nucl. Med. 59 (1948) 771-785
2. Skarsgard L.D. Radiobiology with heavy charged particles: a historical review. Phys. Med. 14 Suppl 1 (1998) 1-19
3. Schulz-Ertner D., and Tsujii H. Particle radiation therapy using proton and heavier ion beams. J. Clin. Oncol. 25 (2007) 953-964
4. Amaldi U., and Kraft G. European developments in radiotherapy with beams of large radiobiological effectiveness. J. Radiat. Res. (Tokyo) 48 Suppl A (2007) A27-A41
5. Karger C.P., and Jakel O. Current status and new developments in ion therapy. Strahlenther. Onkol. 183 (2007) 295-300
6. Kraft G. Radiotherapy with heavy ions: radiobiology, clinical indications and experience at GSI, Darmstadt. Tumori 84 (1998) 200-204
7. T.C.A., Blakely E.A., Ngo F.Q.H., and Curtis S.B. Physical and cellular radiobiological properties of heavy ions in relation to cancer therapy applications. In: Pirncello M.D., and Tobias C.A. (Eds). Biological and medical research with accelerated heavy ions at the Bevalac 1977-1980 (1980) 73-86 LBL 11220, 73-88 1980
8. Tobias C.A., Blakely E.A., Alpen E.L., Castro J.R., Ainsworth E.J., Curtis S.B., Ngo F.Q., Rodriguez A., Roots R.J., Tenforde T., and Yang T.C. Molecular and cellular radiobiology of heavy ions. Int. J. Radiat. Oncol. Biol. Phys. 8 (1982) 2109-2120
9. Schulz-Ertner D., Jakel O., and Schlegel W. Radiation therapy with charged particles. Semin. Radiat. Oncol. 16 (2006) 249-259
10. Kraft G. The radiobiological and physical basis for radiotherapy with protons and heavier ions. Strahlenther. Onkol. 166 (1990) 10-13
11. Kramer M., Weyrather W.K., and Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol. Cancer Res. Treat. 2 (2003) 427-436
12. Weber U., Becher W., and Kraft G. Depth scanning for a conformal ion beam treatment of deep seated tumours. Phys. Med. Biol. 45 (2000) 3627-3641
13. Kramer M., Jakel O., Haberer T., Rietzel E., Schardt D., Scholz M., Wang J.F., Weber U., and Weyrather W. Treatment planning for scanned ion beams. Radiother. Oncol. 73 Suppl 2 (2004) S80-S85
14. Jakel O., Kramer M., Schulz-Ertner D., Heeg P., Karger C.P., Didinger B., Nikoghosyan A., and Debus J. Treatment planning for carbon ion radiotherapy in Germany: review of clinical trials and treatment planning studies. Radiother. Oncol. 73 Suppl 2 (2004) S86-91
15. Kramer M., Jakel O., Haberer T., Kraft G., Schardt D., and Weber U. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys. Med. Biol. 45 (2000) 3299-3317
16. Lomax A.J., Pedroni E., Rutz H., and Goitein G. The clinical potential of intensity modulated proton therapy. Z. Med. Phys. 14 (2004) 147-152
17. Brahme A. Recent advances in light ion radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 603-616
18. Zirkle R.E., and Tobias C.A. Effects of ploidy and linear energy transfer on radiobiological survival curves. Arch. Biochem. Biophys. 47 (1953) 282-306
19. Zirkle R.E. Radiobiological additivity of various ionizing radiations. Am. J. Roentgenol. Radium. Ther. 63 (1950) 170-175
20. Engenhart-Cabillic R., and Wambersie A. Fast neutrons and high-LET particles in cancer therapy. Introduction. Recent Results Cancer Res. 150 (1998) V-IX
21. Enghardt W., Debus J., Haberer T., Hasch B.G., Hinz R., Jakel O., Kramer M., Lauckner K., and Pawelke J. The application of PET to quality assurance of heavy-ion tumor therapy. Strahlenther. Onkol. 175 Suppl 2 (1999) 33-36
22. Parodi K., Paganetti H., Cascio E., Flanz J.B., Bonab A.A., Alpert N.M., Lohmann K., and Bortfeld T. PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants. Med. Phys. 34 (2007) 419-435
23. Weyrather W.K., and Kraft G. RBE of carbon ions: experimental data and the strategy of RBE calculation for treatment planning. Radiother. Oncol. 73 Suppl 2 (2004) S161-S169
24. Scholz M. Effects of radiation on cells and tissue. Adv. in Polymer Science 152 (2003) 95-155
25. Weyrather W.K., Ritter S., Scholz M., and Kraft G. RBE for carbon track-segment irradiation in cell lines of differing repair capacity. Int. J. Radiat. Biol. 75 (1999) 1357-1364
26. Butts J.J., and Katz R. Theory of RBE for heavy ion bombardment of dry enzymes and viruses. Radiat. Res. 30 (1967) 855-871
27. Blakely E.A., Tobias C.A., Yang T.C., Smith K.C., and Lyman J.T. Inactivation of human kidney cells by high-energy monoenergetic heavy-ion beams. Radiat. Res. 80 (1979) 122-160
28. Kanai T., Matsufuji N., Miyamoto T., Mizoe J., Kamada T., Tsuji H., Kato H., Baba M., and Tsujii H. Examination of GyE system for HIMAC carbon therapy. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 650-656
29. Elsasser T., Kramer M., and Scholz M. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys. 71 (2008) 866-872
30. Kraft G., Kramer M., and Scholz M. LET, track structure and models. A review. Radiat. Environ. Biophys. 31 (1992) 161-180
31. Goodhead D.T. Mechanisms for the biological effectiveness of high-LET radiations. J. Radiat. Res. (Tokyo) 40 Suppl (1999) 1-13
32. Goodhead D.T. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int. J. Radiat. Biol. 65 (1994) 7-17
33. Newman H.C., Prise K.M., Folkard M., and Michael B.D. DNA double-strand break distributions in X-ray and alpha-particle irradiated V79 cells: evidence for non-random breakage. Int. J. Radiat. Biol. 71 (1997) 347-363
34. Fouladi B., Waldren C.A., Rydberg B., and Cooper P.K. Comparison of repair of DNA double-strand breaks in identical sequences in primary human fibroblast and immortal hamster-human hybrid cells harboring a single copy of human chromosome 11. Radiat. Res. 153 (2000) 795-804
35. Lobrich M., Cooper P.K., and Rydberg B. Non-random distribution of DNA double-strand breaks induced by particle irradiation. Int. J. Radiat. Biol. 70 (1996) 493-503
36. Taucher-Scholz G., and Kraft G. Influence of radiation quality on the yield of DNA strand breaks in SV40 DNA irradiated in solution. Radiat. Res. 151 (1999) 595-604
37. Brons S., Taucher-Scholz G., Scholz M., and Kraft G. A track structure model for simulation of strand breaks in plasmid DNA after heavy ion irradiation. Radiat. Environ. Biophys. 42 (2003) 63-72
38. Leatherbarrow E.L., Harper J.V., Cucinotta F.A., and O'Neill P. Induction and quantification of gamma-H2AX foci following low and high LET-irradiation. Int. J. Radiat. Biol. 82 (2006) 111-118
39. Gudowska-Nowak E., Nasonova E., Ritter S., and Scholz M. Chromosome fragmentation after irradiation with C ions. Radiother. Oncol. 73 Suppl 2 (2004) S123-126
40. Rydberg B., Cooper B., Cooper P.K., Holley W.R., and Chatterjee A. Dose-dependent misrejoining of radiation-induced DNA double-strand breaks in human fibroblasts: experimental and theoretical study for high- and low-LET radiation. Radiat. Res. 163 (2005) 526-534
41. Kramer M., and Kraft G. Calculations of heavy-ion track structure. Radiat. Environ. Biophys. 33 (1994) 91-109
42. Barendsen G.W. RBE-LET relationships for different types of lethal radiation damage in mammalian cells: comparison with DNA dsb and an interpretation of differences in radiosensitivity. Int. J. Radiat. Biol. 66 (1994) 433-436
43. Schmidt-Bocking H., Ramm U., Kraft G., Ullrich J., Berg H., Kelbch C., Olson R.E., DuBois R., Hagmann S., and Jiazhen F. Delta-electron emission in fast heavy ion atom collisions. Adv. Space Res. 12 (1992) 7-15
44. Gudkov A.V., and Komarova E.A. The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer 3 (2003) 117-129
45. Stiewe T. The p53 family in differentiation and tumorigenesis. Nat. Rev. Cancer 7 (2007) 165-168
46. Iwadate Y., Mizoe J., Osaka Y., Yamaura A., and Tsujii H. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 803-808
47. Takahashi A., Matsumoto H., Yuki K., Yasumoto J., Kajiwara A., Aoki M., Furusawa Y., Ohnishi K., and Ohnishi T. High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 591-597
48. Takahashi A., Ohnishi K., Wang X., Kobayashi M., Matsumoto H., Tamamoto T., Aoki H., Furusawa Y., Yukawa O., and Ohnishi T. The dependence of p53 on the radiation enhancement of thermosensitivity at different let. Int. J. Radiat. Oncol. Biol. Phys. 47 (2000) 489-494
49. Takahashi A., Ohnishi K., Ota I., Asakawa I., Tamamoto T., Furusawa Y., Matsumoto H., and Ohnishi T. p53-dependent thermal enhancement of cellular sensitivity in human squamous cell carcinomas in relation to LET. Int. J. Radiat. Biol. 77 (2001) 1043-1051
50. Asakawa I., Yoshimura H., Takahashi A., Ohnishi K., Nakagawa H., Ota I., Furusawa Y., Tamamoto T., Ohishi H., and Ohnishi T. Radiation-induced growth inhibition in transplanted human tongue carcinomas with different p53 gene status. Anticancer Res. 22 (2002) 2037-2043
51. Oohira G., Yamada S., Ochiai T., Matsubara H., Okazumi S., Ando K., Tsujii H., Hiwasa T., and Shimada H. Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer. Int. J. Oncol. 25 (2004) 563-569
52. Liu B., Zhang H., Zhou G., Xie Y., Hao J., Qiu R., Duan X., and Zhou Q. Adenovirus-mediated p53 gene transfer sensitizes hepatocellular carcinoma cells to heavy-ion radiation. J. Gastroenterol. 42 (2007) 140-145
53. Desai N., Davis E., O'Neill P., Durante M., Cucinotta F.A., and Wu H. Immunofluorescence detection of clustered gamma-H2AX foci induced by HZE-particle radiation. Radiat. Res. 164 (2005) 518-522
54. Antonelli F., Belli M., Cuttone G., Dini V., Esposito G., Simone G., Sorrentino E., and Tabocchini M.A. Induction and repair of DNA double-strand breaks in human cells: dephosphorylation of histone H2AX and its inhibition by calyculin A. Radiat. Res. 164 (2005) 514-517
55. Jakob B., Scholz M., and Taucher-Scholz G. Immediate localized CDKN1A (p21) radiation response after damage produced by heavy-ion tracks. Radiat. Res. 154 (2000) 398-405
56. Scholz M., Jakob B., and Taucher-Scholz G. Direct evidence for the spatial correlation between individual particle traversals and localized CDKN1A (p21) response induced by high-LET radiation. Radiat. Res. 156 (2001) 558-563
57. Jakob B., Scholz M., and Taucher-Scholz G. Biological imaging of heavy charged-particle tracks. Radiat. Res. 159 (2003) 676-684
58. Okayasu R., Okada M., Okabe A., Noguchi M., Takakura K., and Takahashi S. Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous end-joining pathway. Radiat. Res. 165 (2006) 59-67
59. Elsasser T., Brons S., Psonka K., Scholz M., Gudowska-Nowak E., and Taucher-Scholz G. Biophysical modeling of fragment length distributions of DNA plasmids after X and heavy-ion irradiation analyzed by atomic force microscopy. Radiat. Res. 169 (2008) 649-659
60. Brons S., Psonka K., Heiss M., Gudowska-Nowak E., Taucher-Scholz G., and Neumann R. Direct visualisation of heavy ion induced DNA fragmentation using atomic force microscopy. Radiother. Oncol. 73 Suppl 2 (2004) S112-114
61. Heiss M., Fischer B.E., Jakob B., Fournier C., Becker G., and Taucher-Scholz G. Targeted irradiation of mammalian cells using a heavy-ion microprobe. Radiat. Res. 165 (2006) 231-239
62. Brezeanu M., Taucher-Scholz G., Psonka K., Trager F., and Hubenthal F. SFM studies of carbon ion induced damages in plasmid DNA. J. Mol. Recognit. 20 (2007) 502-507
63. Jakob B., Splinter J., Durante M., and Taucher-Scholz G. Live cell microscopy analysis of radiation-induced DNA double-strand break motion. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 3172-3177
64. Suzuki M., Kase Y., Kanai T., and Ando K. Correlation between cell killing and residual chromatin breaks measured by PCC in six human cell lines irradiated with different radiation types. Int. J. Radiat. Biol. 76 (2000) 1189-1196
65. Nasonova E., Gudowska-Nowak E., Ritter S., and Kraft G. Analysis of Ar-ion and X-ray-induced chromatin breakage and repair in V79 plateau-phase cells by the premature chromosome condensation technique. Int. J. Radiat. Biol. 77 (2001) 59-70
66. Suzuki M., Piao C., Hall E.J., and Hei T.K. Cell killing and chromatid damage in primary human bronchial epithelial cells irradiated with accelerated 56Fe ions. Radiat. Res. 155 (2001) 432-439
67. Jeggo P.A., and Lobrich M. Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability. DNA Repair. (Amst) 5 (2006) 1192-1198
68. Pawlik T.M., and Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 59 (2004) 928-942
69. Fournier C., and Taucher-Scholz G. Radiation induced cell cycle arrest: an overview of specific effects following high-LET exposure. Radiother. Oncol. 73 Suppl 2 (2004) S119-122
70. Castro J.R. Results of heavy ion radiotherapy. Radiat. Environ. Biophys. 34 (1995) 45-48
71. Blakely E., Chang P., Lommel L., Bjornstad K., Dixon M., Tobias C., Kumar K., and Blakely W.F. Cell-cycle radiation response: role of intracellular factors. Adv. Space Res. 9 (1989) 177-186
72. Raju M.R., Johnson T.S., Tokita N., Carpenter S., and Jett J.H. Differences in cell-cycle progression delays after exposure to 238Pu alpha particles compared to X rays. Radiat. Res. 84 (1980) 16-24
73. Hieber L., Beck H.P., and Lucke-Huhle C. G2-delay after irradiation with alpha-particles as studied in synchronized cultures and by the bromodeoxyuridine-33258H technique. Cytometry 2 (1981) 175-178
74. Geard C.R. Initial changes in cell cycle progression of Chinese hamster V-79 cells induced by high-LET charged particles. Radiat. Res. 83 (1980) 696-709
75. Goto S., Watanabe M., and Yatagai F. Delayed cell cycle progression in human lymphoblastoid cells after exposure to high-LET radiation correlates with extremely localized DNA damage. Radiat. Res. 158 (2002) 678-686
76. Tsuboi K., Tsuchida Y., Nose T., and Ando K. Cytotoxic effect of accelerated carbon beams on glioblastoma cell lines with p53 mutation: clonogenic survival and cell-cycle analysis. Int. J. Radiat. Biol. 74 (1998) 71-79
77. Azzam E.I., de Toledo S.M., Waker A.J., and Little J.B. High and low fluences of alpha-particles induce a G1 checkpoint in human diploid fibroblasts. Cancer Res. 60 (2000) 2623-2631
78. Gadbois D.M., Crissman H.A., Nastasi A., Habbersett R., Wang S.K., Chen D., and Lehnert B.E. Alterations in the progression of cells through the cell cycle after exposure to alpha particles or gamma rays. Radiat. Res. 146 (1996) 414-424
79. Mothersill C., and Seymour C. Radiation-induced bystander effects: past history and future directions. Radiat. Res. 155 (2001) 759-767
80. Belyakov O.V., Malcolmson A.M., Folkard M., Prise K.M., and Michael B.D. Direct evidence for a bystander effect of ionizing radiation in primary human fibroblasts. Br. J. Cancer 84 (2001) 674-679
81. Fournier C., Becker D., Winter M., Barberet P., Heiss M., Fischer B., Topsch J., and Taucher-Scholz G. Cell cycle-related bystander responses are not increased with LET after heavy-ion irradiation. Radiat. Res. 167 (2007) 194-206
82. Tartier L., Gilchrist S., Burdak-Rothkamm S., Folkard M., and Prise K.M. Cytoplasmic irradiation induces mitochondrial-dependent 53BP1 protein relocalization in irradiated and bystander cells. Cancer Res. 67 (2007) 5872-5879
83. Shao C., Folkard M., Michael B.D., and Prise K.M. Targeted cytoplasmic irradiation induces bystander responses. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13495-13500
84. Shao C., Furusawa Y., Aoki M., Matsumoto H., and Ando K. Nitric oxide-mediated bystander effect induced by heavy-ions in human salivary gland tumour cells. Int. J. Radiat. Biol. 78 (2002) 837-844
85. Shao C., Aoki M., and Furusawa Y. Bystander effect on cell growth stimulation in neoplastic HSGc cells induced by heavy-ion irradiation. Radiat. Environ. Biophys. 42 (2003) 183-187
86. Shao C., Furusawa Y., Aoki M., and Ando K. Role of gap junctional intercellular communication in radiation-induced bystander effects in human fibroblasts. Radiat. Res. 160 (2003) 318-323
87. Shao C., Folkard M., and Prise K.M. Role of TGF-beta1 and nitric oxide in the bystander response of irradiated glioma cells. Oncogene 27 (2008) 434-440
88. Yang H., Anzenberg V., and Held K.D. The time dependence of bystander responses induced by iron-ion radiation in normal human skin fibroblasts. Radiat. Res. 168 (2007) 292-298
89. Kanasugi Y., Hamada N., Wada S., Funayama T., Sakashita T., Kakizaki T., Kobayashi Y., and Takakura K. Role of DNA-PKcs in the bystander effect after low- or high-LET irradiation. Int. J. Radiat. Biol. 83 (2007) 73-80
90. Hamada N., Ni M., Funayama T., Sakashita T., and Kobayashi Y. Temporally distinct response of irradiated normal human fibroblasts and their bystander cells to energetic heavy ions. Mutat. Res. 639 (2008) 35-44
91. Groesser T., Cooper B., and Rydberg B. Lack of bystander effects from high-LET radiation for early cytogenetic end points. Radiat. Res. 170 (2008) 794-802
92. Sokolov M.V., Smilenov L.B., Hall E.J., Panyutin I.G., Bonner W.M., and Sedelnikova O.A. Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts. Oncogene 24 (2005) 7257-7265
93. Dimitrijevic-Bussod M., Balzaretti-Maggi V.S., and Gadbois D.M. Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts. Cancer Res. 59 (1999) 4843-4847
94. Vaupel P., Kelleher D.K., and Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin. Oncol. 28 (2001) 29-35
95. Hall E.J. Hall Radiobiology for the Radiologist (1988), Lippincot, Philadelphia
96. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14 (2004) 198-206
97. Wambersie A., Hendry J., Gueulette J., Gahbauer R., Potter R., and Gregoire V. Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. Radiother. Oncol. 73 Suppl 2 (2004) S1-14
98. Barendsen G.W., Walter H.M., Fowler J.F., and Bewley D.K. Effects of different ionizing radiations on human cells in tissue culture. III. Experiments with cyclotron-accelerated alpha-particles and deuterons. Radiat. Res. 18 (1963) 106-119
99. Chapman J.D., Urtasun R.C., Blakely E.A., Smith K.C., and Tobias C.A. Hypoxic cell sensitizers and heavy charged-particle radiations. Br. J. Cancer Suppl. 3 (1978) 184-188
100. Curtis S.B., Tenforde T.S., and Afzal S.M. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 10 (1984) 1203-1205
101. Furusawa Y., Fukutsu K., Aoki M., Itsukaichi H., Eguchi-Kasai K., Ohara H., Yatagai F., Kanai T., and Ando K. Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Ne-ion beams. Radiat. Res. 154 (2000) 485-496
102. Oya N., Sasai K., Shibata T., Takagi T., Shibuya K., Koike S., Nojima K., Furusawa Y., Ando K., and Hiraoka M. Time course of reoxygenation in experimental murine tumors after carbon-beam and X-ray irradiation. J. Radiat. Res. (Tokyo) 42 (2001) 131-141
103. Fukawa T., Takematsu K., Oka K., Koike S., Ando K., Kobayashi H., and Tanishita K. Differences in pO2 peaks of a murine fibrosarcoma between carbon-ion and X-ray irradiation. J. Radiat. Res. (Tokyo) 45 (2004) 303-308
104. Guichard M., Tenforde T., Curtis S., and Malaise E.P. Effect of combined misonidazole and accelerated neon ions on a human melanoma transplanted into nude mice. Radiology 142 (1982) 219-223
105. Tenforde T.S., Curtis S.B., Parr S.S., Afzal S.M., Howard J., and Lyman J.T. Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 41 (1982) 677-684
106. Tenforde T.S., Curtis S.B., Tenforde S.D., Parr S.S., Crabtree K.E., Flynn M.J., Howard J., and Lyman J.T. Misonidazole enhancement of radiation-induced growth delay in rat rhabdomyosarcoma tumours exposed to accelerated carbon and neon ions. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 40 (1981) 117-129
107. Wambersie A., Bewley D.K., and Lalanne C.M. Prospects for the application of fast neutrons in cancer therapy. Radiobiological bases and survey of the clinical data. Bull. Cancer 73 (1986) 546-561
108. Warenius H.M., White R., Peacock J.H., Hanson J., Britten R.A., and Murray D. The influence of hypoxia on the relative sensitivity of human tumor cells to 62.5 MeV (p-->Be) fast neutrons and 4 MeV photons. Radiat. Res. 154 (2000) 54-63
109. Nakano T., Suzuki Y., Ohno T., Kato S., Suzuki M., Morita S., Sato S., Oka K., and Tsujii H. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin. Cancer Res. 12 (2006) 2185-2190
110. Quintiliani M. The oxygen effect in radiation inactivation of DNA and enzymes. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 50 (1986) 573-594
111. Moritake T., Tsuboi K., Anzai K., Ozawa T., Ando K., and Nose T. ESR spin trapping of hydroxyl radicals in aqueous solution irradiated with high-LET carbon-ion beams. Radiat. Res. 159 (2003) 670-675
112. Taguchi M., and Kojima T. Yield of OH radicals in water under high-density energy deposition by heavy-ion irradiation. Radiat. Res. 163 (2005) 455-461
113. LaVerne J.A. Track effects of heavy ions in liquid water. Radiat. Res. 153 (2000) 487-496
114. Di Pietro C., Piro S., Tabbi G., Ragusa M., Di Pietro V., Zimmitti V., Cuda F., Anello M., Consoli U., Salinaro E.T., Caruso M., Vancheri C., Crimi N., Sabini M.G., Cirrone G.A., Raffaele L., Privitera G., Pulvirenti A., Giugno R., Ferro A., Cuttone G., Lo Nigro S., Purrello R., Purrello F., and Purrello M. Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis 11 (2006) 57-66
115. Lee K.B., Lee J.S., Park J.W., Huh T.L., and Lee Y.M. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp. Mol. Med. 40 (2008) 118-129
116. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
117. Moeller B.J., Cao Y., Li C.Y., and Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 (2004) 429-441
118. Sonveaux P., Brouet A., Havaux X., Gregoire V., Dessy C., Balligand J.L., and Feron O. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res. 63 (2003) 1012-1019
119. Park C.M., Park M.J., Kwak H.J., Lee H.C., Kim M.S., Lee S.H., Park I.C., Rhee C.H., and Hong S.I. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res. 66 (2006) 8511-8519
120. Chung Y.L., Jian J.J., Cheng S.H., Tsai S.Y., Chuang V.P., Soong T., Lin Y.M., and Horng C.F. Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clin. Cancer Res. 12 (2006) 2706-2715
121. Ando S., Nojima K., Ishihara H., Suzuki M., Ando M., Majima H., Ando K., and Kuriyama T. Induction by carbon-ion irradiation of the expression of vascular endothelial growth factor in lung carcinoma cells. Int. J. Radiat. Biol. 76 (2000) 1121-1127
122. Chang P.Y., Bjornstad K.A., Chang E., McNamara M., Barcellos-Hoff M.H., Lin S.P., Aragon G., Polansky J.R., Lui G.M., and Blakely E.A. Particle irradiation induces FGF2 expression in normal human lens cells. Radiat. Res. 154 (2000) 477-484
123. McNamara M.P., Bjornstad K.A., Chang P.Y., Chou W., Lockett S.J., and Blakely E.A. Modulation of lens cell adhesion molecules by particle beams. Phys. Med. 17 Suppl 1 (2001) 247-248
124. Chang P.Y., Bjornstad K.A., Rosen C.J., Lin S., and Blakely E.A. Particle radiation alters expression of matrix metalloproteases resulting in ECM remodeling in human lens cells. Radiat. Environ. Biophys. 46 (2007) 187-194
125. Du G., Fischer B.E., Voss K.O., Becker G., Taucher-Scholz G., Kraft G., and Thiel G. The absence of an early calcium response to heavy-ion radiation in mammalian cells. Radiat. Res. 170 (2008) 316-326
126. Takahashi Y., Teshima T., Kawaguchi N., Hamada Y., Mori S., Madachi A., Ikeda S., Mizuno H., Ogata T., Nojima K., Furusawa Y., and Matsuura N. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res. 63 (2003) 4253-4257
127. Jang G.H., Ha J.H., Huh T.L., and Lee Y.M. Effect of proton beam on blood vessel formation in early developing zebrafish (Danio rerio) embryos. Arch. Pharm. Res. 31 (2008) 779-785
128. Vernimmen F.J., Slabbert J.P., Wilson J.A., Fredericks S., and Melvill R. Stereotactic proton beam therapy for intracranial arteriovenous malformations. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 44-52
129. Ogata T., Teshima T., Kagawa K., Hishikawa Y., Takahashi Y., Kawaguchi A., Suzumoto Y., Nojima K., Furusawa Y., and Matsuura N. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 65 (2005) 113-120
130. Goetze K., Scholz M., Taucher-Scholz G., and Mueller-Klieser W. The impact of conventional and heavy ion irradiation on tumor cell migration in vitro. Int. J. Radiat. Biol. 83 (2007) 889-896
131. Combs S.E., Nikoghosyan A., Jaekel O., Karger C.P., Haberer T., Munter M.W., Huber P.E., Debus J., and Schulz-Ertner D. Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer 115 (2009) 1348-1355
132. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Oncol. Biol. Phys. 65 (2006) 1-7
133. Jakel O., Kramer M., Karger C.P., and Debus J. Treatment planning for heavy ion radiotherapy: clinical implementation and application. Phys. Med. Biol. 46 (2001) 1101-1116
134. Tsujii H., Mizoe J., Kamada T., Baba M., Tsuji H., Kato H., Kato S., Yamada S., Yasuda S., Ohno T., Yanagi T., Imai R., Kagei K., Hara R., Hasegawa A., Nakajima M., Sugane N., Tamaki N., Takagi R., Kandatsu S., Yoshikawa K., Kishimoto R., and Miyamoto T. Clinical results of carbon ion radiotherapy at NIRS. J. Radiat. Res. (Tokyo) 48 Suppl A (2007) A1-A13
135. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat. Rev. Cancer 6 (2006) 702-713
136. Tsoutsou P.G., and Koukourakis M.I. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int. J. Radiat. Oncol. Biol. Phys. 66 (2006) 1281-1293
137. Fournier C., Kraft-Weyrather W., and Kraft G. Survival, differentiation and collagen secretion of human fibroblasts after irradiation with carbon ions and X-rays. Phys. Med. 14 Suppl 1 (1998) 44-47
138. Haase O., and Rodemann H.P. Fibrosis and cytokine mechanisms: relevant in hadron therapy?. Radiother. Oncol. 73 Suppl 2 (2004) S144-147
139. Gridley D.S., Bonnet R.B., Bush D.A., Franke C., Cheek G.A., Slater J.D., and Slater J.M. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 759-766
140. Nishimura H., Miyamoto T., Yamamoto N., Koto M., Sugimura K., and Tsujii H. Radiographic pulmonary and pleural changes after carbon ion irradiation. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 861-866
141. Nihei K., Ogino T., Ishikura S., and Nishimura H. High-dose proton beam therapy for stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 65 (2006) 107-111
142. Kiger J.L., Kiger III W.S., Riley K.J., Binns P.J., Patel H., Hopewell J.W., Harling O.K., Busse P.M., and Coderre J.A. Functional and histological changes in rat lung after boron neutron capture therapy. Radiat. Res. 170 (2008) 60-69
143. Reder C.S., Moyers M.F., Lau D., and Kirby M.A. Studies of physiology and the morphology of the cat LGN following proton irradiation. Int. J. Radiat. Oncol. Biol. Phys. 46 (2000) 1247-1257
144. Okeda R., Okada S., Kawano A., Matsushita S., and Kuroiwa T. Neuropathology of delayed encephalopathy in cats induced by heavy-ion irradiation. J. Radiat. Res. (Tokyo) 44 (2003) 345-352
145. Inouye M., Hayasaka S., Takahashi S., Kubota Y., and Murata Y. A comparison of effects between accelerated heavy ion irradiation and X-irradiation on the development of rat cerebellum. Environ. Med. 43 (1999) 69-71
146. Wang B., Murakami M., Eguchi-Kasai K., Nojima K., Shang Y., Tanaka K., Fujita K., Coffigny H., and Hayata I. Effects of prenatal irradiation with an accelerated heavy-ion beam on postnatal development in rats: I. Neurophysiological alterations. Radiat. Res. 164 (2005) 561-566
147. Keng P.C., and Lett J.T. Effects of heavy ions on rabbit tissues: loss of electroretinogram and DNA repair in retinal photoreceptor cells. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 39 (1981) 655-664
148. Vazquez M.E., and Kirk E. In vitro neurotoxic effects of 1 GeV/n iron particles assessed in retinal explants. Adv. Space Res. 25 (2000) 2041-2049
149. Keng P.C., Bergtold D.S., and Lett J.T. Effects of heavy ions on rabbit tissues: analysis of low levels of DNA damage in retinal photoreceptor cells. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 43 (1983) 219-229
150. Blakely E.A., and Chang P.Y. Late effects from hadron therapy. Radiother. Oncol. 73 Suppl 2 (2004) S134-140
151. Blakely E.A., Daftari I.K., Meecham W.J., Alonso L.C., Collier J.M., Kroll S.M., Gillette E.L., Lee A.C., Lett J.T., Cox A.B., Castro J.R., and Char D.H. Helium-ion-induced human cataractogenesis. Adv. Space Res. 14 (1994) 501-505
152. Meecham W.J., Char D.H., Kroll S., Castro J.R., and Blakely E.A. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract. Arch. Ophthalmol. 112 (1994) 197-203
153. Kishimoto R., Mizoe J.E., Komatsu S., Kandatsu S., Obata T., and Tsujii H. MR imaging of brain injury induced by carbon ion radiotherapy for head and neck tumors. Magn. Reson. Med. Sci. 4 (2005) 159-164
154. Takahashi K., Monzen S., Eguchi-Kasai K., Abe Y., and Kashiwakura I. Severe damage of human megakaryocytopoiesis and thrombopoiesis by heavy-ion beam radiation. Radiat. Res. 168 (2007) 545-551
155. Takahashi K., Monzen S., Yoshino H., Abe Y., Eguchi-Kasai K., and Kashiwakura I. Effects of a 2-step culture with cytokine combinations on megakaryocytopoiesis and thrombopoiesis from carbon-ion beam-irradiated human hematopoietic stem/progenitor cells. J. Radiat. Res. (Tokyo) 49 (2008) 417-424
156. Tu Z.L., Kobayashi Y., Kiguchi K., Watanabe H., and Yamamoto K. Effects of heavy-ion radiosurgery on the hemopoietic function of the silkworm Bombyx mori. J. Radiat. Res. (Tokyo) 43 (2002) 269-275
157. Gridley D.S., Dutta-Roy R., Andres M.L., Nelson G.A., and Pecaut M.J. Acute effects of iron-particle radiation on immunity. Part II: leukocyte activation, cytokines and adhesion. Radiat. Res. 165 (2006) 78-87
158. Ishikawa H., Tsuji H., Kamada T., Hirasawa N., Yanagi T., Mizoe J.E., Akakura K., Suzuki H., Shimazaki J., Nakano T., and Tsujii H. Adverse effects of androgen deprivation therapy on persistent genitourinary complications after carbon ion radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. (2008)
159. Wakatsuki M., Tsuji H., Ishikawa H., Yanagi T., Kamada T., Nakano T., Suzuki H., Akakura K., Shimazaki J., and Tsujii H. Quality of life in men treated with carbon ion therapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 72 (2008) 1010-1015
160. Ishikawa H., Tsuji H., Kamada T., Hirasawa N., Yanagi T., Mizoe J.E., Akakura K., Suzuki H., Shimazaki J., and Tsujii H. Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 66 (2006) 1084-1091
161. Barcellos-Hoff M.H., Park C., and Wright E.G. Radiation and the microenvironment - tumorigenesis and therapy. Nat. Rev. Cancer 5 (2005) 867-875
162. Tenhumberg S., Gudowska-Nowak E., Nasonova E., and Ritter S. Cell cycle arrest and aberration yield in normal human fibroblasts. II: Effects of 11 MeV u-1 C ions and 9.9 MeV u-1 Ni ions. Int. J. Radiat. Biol. 83 (2007) 501-513
163. Nasonova E., Fussel K., Berger S., Gudowska-Nowak E., and Ritter S. Cell cycle arrest and aberration yield in normal human fibroblasts. I. Effects of X-rays and 195 MeV u(- 1) C ions. Int. J. Radiat. Biol. 80 (2004) 621-634
164. Fournier C., Winter M., Zahnreich S., Nasonova E., Melnikova L., and Ritter S. Interrelation amongst differentiation, senescence and genetic instability in long-term cultures of fibroblasts exposed to different radiation qualities. Radiother. Oncol. 83 (2007) 277-282
165. Durante M., and Cucinotta F.A. Heavy ion carcinogenesis and human space exploration. Nat. Rev. Cancer 8 (2008) 465-472
166. Durante M. Heavy ion radiobiology for hadrontherapy and space radiation protection. Radiother. Oncol. 73 Suppl 2 (2004) S158-160
167. Durante M., George K., Wu H., and Cucinotta F.A. Karyotypes of human lymphocytes exposed to high-energy iron ions. Radiat. Res. 158 (2002) 581-590
168. Kagawa Y., Shimazu T., Gordon A.J., Fukunishi N., Inabe N., Suzuki M., Hirano M., Kato T., Watanabe M., Hanaoka F., and Yatagai F. Complex hprt deletion events are recovered after exposure of human lymphoblastoid cells to high-LET carbon and neon ion beams. Mutagenesis 14 (1999) 199-205
169. Kagawa Y., Yatagai F., Suzuki M., Kase Y., Kobayashi A., Hirano M., Kato T., Watanabe M., and Hanaoka F. Analysis of mutations in the human HPRT gene induced by accelerated heavy-ion irradiation. J. Radiat. Res. (Tokyo) 36 (1995) 185-195
170. Tsuruoka C., Suzuki M., and Fujitaka K. LET and ion-species dependence for mutation induction and mutation spectrum on hprt locus in normal human fibroblasts. Biol. Sci. Space 18 (2004) 188-189
171. Suzuki M., Tsuruoka C., Kanai T., Kato T., Yatagai F., and Watanabe M. Qualitative and quantitative difference in mutation induction between carbon- and neon-ion beams in normal human cells. Biol. Sci. Space 17 (2003) 302-306
172. Tsuruoka C., Suzuki M., and Fujitaka K. LET and ion-species dependence for cell killing and mutation induction in normal human fibroblasts. Biol. Sci. Space 17 (2003) 185-186
173. Albertini R.J., Clark L.S., Nicklas J.A., O'Neill J.P., Hui T.E., and Jostes R. Radiation quality affects the efficiency of induction and the molecular spectrum of HPRT mutations in human T cells. Radiat. Res. 148 (1997) S76-86
174. O'Neill P., Nicklas J., Hirsch B., Jostes R., Hunter T., Sullivan L., and Albertini R. In vitro studies of the genotoxicity of ionizing radiation in human G(0) T lymphocytes. Environ. Mol. Mutagen. 46 (2005) 207-220
175. Shigematsu N., Ihara N., Kawata T., Kawaguchi O., Takeda A., Ishibashi R., Kutsuki S., Kubo A., Kanai T., Furusawa Y., Isobe K., Uno T., and Ito H. Cell killing and mutation induction by heavy ion beams. Int. J. Mol. Med. 7 (2001) 509-513
176. Kadhim M.A., Lorimore S.A., Hepburn M.D., Goodhead D.T., Buckle V.J., and Wright E.G. Alpha-particle-induced chromosomal instability in human bone marrow cells. Lancet 344 (1994) 987-988
177. Kadhim M.A., Macdonald D.A., Goodhead D.T., Lorimore S.A., Marsden S.J., and Wright E.G. Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature 355 (1992) 738-740
178. Lorimore S.A., Kadhim M.A., Pocock D.A., Papworth D., Stevens D.L., Goodhead D.T., and Wright E.G. Chromosomal instability in the descendants of unirradiated surviving cells after alpha-particle irradiation. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5730-5733
179. Singleton B.K., Griffin C.S., and Thacker J. Clustered DNA damage leads to complex genetic changes in irradiated human cells. Cancer Res. 62 (2002) 6263-6269
180. Wiese C., Gauny S.S., Liu W.C., Cherbonnel-Lasserre C.L., and Kronenberg A. Different mechanisms of radiation-induced loss of heterozygosity in two human lymphoid cell lines from a single donor. Cancer Res. 61 (2001) 1129-1137
181. Morimoto S., Honma M., and Yatagai F. Sensitive detection of LOH events in a human cell line after C-ion beam exposure. J. Radiat. Res. (Tokyo) 43 Suppl (2002) S163-S167
182. Yatagai F., Morimoto S., Kato T., and Honma M. Further characterization of loss of heterozygosity enhanced by p53 abrogation in human lymphoblastoid TK6 cells: disappearance of endpoint hotspots. Mutat. Res. 560 (2004) 133-145
183. Piao C.Q., and Hei T.K. Gene amplification and microsatellite instability induced in tumorigenic human bronchial epithelial cells by alpha particles and heavy ions. Radiat. Res. 155 (2001) 263-267
184. Hofman-Huther H., Peuckert H., Ritter S., and Virsik-Kopp P. Chromosomal instability and delayed apoptosis in long-term T-lymphocyte cultures irradiated with carbon ions and x rays. Radiat. Res. 166 (2006) 858-869
185. Sekine E., Okada M., Matsufuji N., Yu D., Furusawa Y., and Okayasu R. High LET heavy ion radiation induces lower numbers of initial chromosome breaks with minimal repair than low LET radiation in normal human cells. Mutat. Res. 652 (2008) 95-101
186. Jianshe Y., Wenjian L., Xiaodong J., Xigang J., Chuanling G., Wei W., and Qingxiang G. Survival and initial chromatid breakage in normal and tumour cells exposed in vitro to gamma rays and carbon ions at the HIRFL. Br. J. Radiol. 79 (2006) 518-521
187. Ofuchi T., Suzuki M., Kase Y., Ando K., Isono K., and Ochiai T. Chromosome breakage and cell lethality in human hepatoma cells irradiated with X rays and carbon-ion beams. J. Radiat. Res. (Tokyo) 40 (1999) 125-133
188. Waldren C.A., Vannais D.B., and Ueno A.M. A role for long-lived radicals (LLR) in radiation-induced mutation and persistent chromosomal instability: counteraction by ascorbate and RibCys but not DMSO. Mutat. Res. 551 (2004) 255-265
189. Ueno A., Vannais D., Lenarczyk M., and Waldren C.A. Ascorbate, added after irradiation, reduces the mutant yield and alters the spectrum of CD59- mutations in A(L) cells irradiated with high LET carbon ions. J. Radiat. Res. (Tokyo) 43 (2002) S245-S249
190. Engels H., Menzel H.G., Pihet P., and Wambersie A. Risk assessment for cancer induction after low- and high-LET therapeutic irradiation. Strahlenther. Onkol. 175 Suppl 2 (1999) 47-51
191. Engels H., and Wambersie A. Relative biological effectiveness of neutrons for cancer induction and other late effects: a review of radiobiological data. Recent Results Cancer Res. 150 (1998) 54-87
192. Borek C., Hall E.J., and Rossi H.H. Malignant transformation in cultured hamster embryo cells produced by X-rays, 460-keV monoenergetic neutrons, and heavy ions. Cancer Res. 38 (1978) 2997-3005
193. Miller R.C., Marino S.A., Martin S.G., Komatsu K., Geard C.R., Brenner D.J., and Hall E.J. Neutron-energy-dependent cell survival and oncogenic transformation. J. Radiat. Res. (Tokyo) 40 Suppl (1999) 53-59
194. Miller R.C., Marino S.A., Napoli J., Shah H., Hall E.J., Geard C.R., and Brenner D.J. Oncogenic transformation in C3H10T1/2 cells by low-energy neutrons. Int. J. Radiat. Biol. 76 (2000) 327-333
195. Shellabarger C.J., Chmelevsky D., Kellerer A.M., Stone J.P., and Holtzman S. Induction of mammary neoplasms in the ACI rat by 430-keV neutrons, X-rays, and diethylstilbestrol. J. Natl. Cancer Inst. 69 (1982) 1135-1146
196. Shellabarger C.J., Chmelevsky D., and Kellerer A.M. Induction of mammary neoplasms in the Sprague-Dawley rat by 430 keV neutrons and X-rays. J. Natl. Cancer Inst. 64 (1980) 821-833
197. Shellabarger C.J., Stone J.P., and Holtzman S. Synergism between neutron radiation and diethylstilbestrol in the production of mammary adenocarcinomas in the rat. Cancer Res. 36 (1976) 1019-1022
198. Bettega D., Calzolari P., Costa A., Chiorda G.N., and Tallone L. Oncogenic transformation of C3H 10 T1/2 cells exposed to alpha particles: sensitivity through the cell cycle. Radiat. Res. 142 (1995) 276-280
199. Bettega D., Calzolari P., Piazzolla A., Tallone L., and Redpath J.L. Alpha-particle-induced neoplastic transformation in synchronized hybrid cells of HeLa and human skin fibroblasts. Int. J. Radiat. Biol. 72 (1997) 523-529
200. Miller R.C., Randers-Pehrson G., Geard C.R., Hall E.J., and Brenner D.J. The oncogenic transforming potential of the passage of single alpha particles through mammalian cell nuclei. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 19-22
201. Bettega D. Cell transformation by light charged particles: review of available data. Radiother. Oncol. 73 Suppl 2 (2004) S155-157
202. Alpen E.L., Powers-Risius P., Curtis S.B., and DeGuzman R. Tumorigenic potential of high-Z, high-LET charged-particle radiations. Radiat. Res. 136 (1993) 382-391
203. Watanabe H., Ogiu T., Nishizaki M., Fujimoto N., Kido S., Ishimura Y., Shiraki K., Kuramoto K., Hirata S., Shoji S., and Katoh O. Induction of ovarian tumors by heavy ion irradiation in B6C3F1 mice. Oncol. Rep. 5 (1998) 1377-1380
204. Zhao Y., Shao G., Piao C.Q., Berenguer J., and Hei T.K. Down-regulation of Betaig-h3 gene is involved in the tumorigenesis in human bronchial epithelial cells induced by heavy-ion radiation. Radiat. Res. 162 (2004) 655-659
205. Imaoka T., Nishimura M., Kakinuma S., Hatano Y., Ohmachi Y., Yoshinaga S., Kawano A., Maekawa A., and Shimada Y. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations. Int. J. Radiat. Oncol. Biol. Phys. 69 (2007) 194-203
206. Hei T.K., Zhao Y.L., Roy D., Piao C.Q., Calaf G., and Hall E.J. Molecular alterations in tumorigenic human bronchial and breast epithelial cells induced by high LET radiation. Adv. Space Res. 27 (2001) 411-419
207. Brenner D.J., and Hall E.J. Secondary neutrons in clinical proton radiotherapy: a charged issue. Radiother. Oncol. 86 (2008) 165-170
208. Schneider U., Lomax A., and Timmermann B. Second cancers in children treated with modern radiotherapy techniques. Radiother. Oncol. (2008)
209. Schneider U., Lomax A., Pemler P., Besserer J., Ross D., Lombriser N., and Kaser-Hotz B. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther. Onkol. 182 (2006) 647-652
210. Schneider U., Lomax A., and Lombriser N. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat. Res. 154 (2000) 382-388
211. Miralbell R., Lomax A., Cella L., and Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int. J. Radiat. Oncol. Biol. Phys. 54 (2002) 824-829
212. Schulz-Ertner D., Karger C.P., Feuerhake A., Nikoghosyan A., Combs S.E., Jakel O., Edler L., Scholz M., and Debus J. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int. J. Radiat. Oncol. Biol. Phys. 68 (2007) 449-457
213. Schulz-Ertner D., Nikoghosyan A., Hof H., Didinger B., Combs S.E., Jakel O., Karger C.P., Edler L., and Debus J. Carbon ion radiotherapy of skull base chondrosarcomas. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007) 171-177
214. Mizoe J.E., Tsujii H., Kamada T., Matsuoka Y., Tsuji H., Osaka Y., Hasegawa A., Yamamoto N., Ebihara S., and Konno A. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 358-364
215. Schulz-Ertner D., Nikoghosyan A., Didinger B., Munter M., Jakel O., Karger C.P., and Debus J. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 104 (2005) 338-344
216. Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol. 44 (2005) 265-276
217. Ishikawa H., Tsuji H., Kamada T., Yanagi T., Mizoe J.E., Kanai T., Morita S., Wakatsuki M., Shimazaki J., and Tsujii H. Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. Radiother. Oncol. 81 (2006) 57-64
218. Akakura K., Tsujii H., Morita S., Tsuji H., Yagishita T., Isaka S., Ito H., Akaza H., Hata M., Fujime M., Harada M., and Shimazaki J. Phase I/II clinical trials of carbon ion therapy for prostate cancer. Prostate 58 (2004) 252-258
219. Zelefsky M.J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C.C., Amols H., Venkatraman E.S., and Leibel S.A. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 1111-1116
220. Zietman A.L., DeSilvio M.L., Slater J.D., Rossi Jr. C.J., Miller D.W., Adams J.A., and Shipley W.U. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
221. Kawashima M., Furuse J., Nishio T., Konishi M., Ishii H., Kinoshita T., Nagase M., Nihei K., and Ogino T. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J. Clin. Oncol. 23 (2005) 1839-1846
222. Bush D.A., Hillebrand D.J., Slater J.M., and Slater J.D. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 127 (2004) S189-193
223. Chiba T., Tokuuye K., Matsuzaki Y., Sugahara S., Chuganji Y., Kagei K., Shoda J., Hata M., Abei M., Igaki H., Tanaka N., and Akine Y. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin. Cancer Res. 11 (2005) 3799-3805
224. Kato H., Tsujii H., Miyamoto T., Mizoe J.E., Kamada T., Tsuji H., Yamada S., Kandatsu S., Yoshikawa K., Obata T., Ezawa H., Morita S., Tomizawa M., Morimoto N., Fujita J., and Ohto M. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int. J. Radiat. Oncol. Biol. Phys. 59 (2004) 1468-1476
225. Imai R., Kamada T., Tsuji H., Yanagi T., Baba M., Miyamoto T., Kato S., Kandatsu S., Mizoe J.E., Tsujii H., and Tatezaki S. Carbon ion radiotherapy for unresectable sacral chordomas. Clin. Cancer Res. 10 (2004) 5741-5746
226. Kamada T., Tsujii H., Tsuji H., Yanagi T., Mizoe J.E., Miyamoto T., Kato H., Yamada S., Morita S., Yoshikawa K., Kandatsu S., and Tateishi A. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J. Clin. Oncol. 20 (2002) 4466-4471
227. Serizawa I., Kagei K., Kamada T., Imai R., Sugahara S., Okada T., Tsuji H., Ito H., and Tsujii H. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int. J. Radiat. Oncol. Biol. Phys. (2009)
228. Schulz-Ertner D., Nikoghosyan A., Thilmann C., Haberer T., Jakel O., Karger C., Kraft G., Wannenmacher M., and Debus J. Results of carbon ion radiotherapy in 152 patients. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 631-640
229. Bush D.A., Slater J.D., Shin B.B., Cheek G., Miller D.W., and Slater J.M. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126 (2004) 1198-1203
230. Shioyama Y., Tokuuye K., Okumura T., Kagei K., Sugahara S., Ohara K., Akine Y., Ishikawa S., Satoh H., and Sekizawa K. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 7-13
231. Miyamoto T., Baba M., Yamamoto N., Koto M., Sugawara T., Yashiro T., Kadono K., Ezawa H., Tsujii H., Mizoe J.E., Yoshikawa K., Kandatsu S., and Fujisawa T. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007) 750-758
232. Miyamoto T., Baba M., Sugane T., Nakajima M., Yashiro T., Kagei K., Hirasawa N., Sugawara T., Yamamoto N., Koto M., Ezawa H., Kadono K., Tsujii H., Mizoe J.E., Yoshikawa K., Kandatsu S., and Fujisawa T. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J. Thorac. Oncol. 2 (2007) 916-926
233. Thames Jr. H.D., Withers H.R., Peters L.J., and Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int. J. Radiat. Oncol. Biol. Phys. 8 (1982) 219-226
234. Denekamp J., Waites T., and Fowler J.F. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int. J. Radiat. Biol. 71 (1997) 681-694
235. Ando K., Koike S., Uzawa A., Takai N., Fukawa T., Furusawa Y., Aoki M., and Miyato Y. Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J. Radiat. Res. (Tokyo) 46 (2005) 51-57
236. Battermann J.J., Breur K., Hart G.A., and van Peperzeel H.A. Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays. Eur. J. Cancer 17 (1981) 539-548
237. Sugane T., Baba M., Imai R., Nakajima M., Yamamoto N., Miyamoto T., Ezawa H., Yoshikawa K., Kandatsu S., Kamada T., Mizoe J., and Tsujii H. Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. Lung Cancer 64 (2009) 45-50
238. Nikoghosyan A., Schulz-Ertner D., Didinger B., Jakel O., Zuna I., Hoss A., Wannenmacher M., and Debus J. Evaluation of therapeutic potential of heavy ion therapy for patients with locally advanced prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 89-97
239. Uzawa A., Ando K., Koike S., Furusawa Y., Matsumoto Y., Takai N., Hirayama R., Watanabe M., Scholz M., Elsasser T., and Peschke P. Comparison of biological effectiveness of carbon-ion beams in Japan and Germany. Int. J. Radiat. Oncol. Biol. Phys. 73 (2009) 1545-1551